V

Vivoryon Therapeutics
VVY

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€47.18M
EV
€31.92M
Shares Outstanding
26.07M
Beta
1.97

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
€5.50
P/E 2024E
-
P/Revenue 2024E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Vivoryon Therapeutics N.V.

gainify

V

Vivoryon Therapeutics N.V.

VVY

Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-A...

Sector

Healthcare

Industry

Biotechnology

CEO

Weber, Frank

Employees

15

IPO Date

2014-10-27

Headquarters

Weinbergweg 22, Halle, Saxony-Anhalt, 06120, Germany

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved